ACOR: Message Board for Acorda Therapeutics, Inc. - InvestorVillage


Acorda Therapeutics, Inc.

  ACOR website

ACOR   /  Message Board

 
BOARD

GROUPS
 





 
Loading...
 
 
--




Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
80 Catalent Agrees to Acquire Dry Powder Inhaler Spray Drying, Capsule Manufacturing, and Packaging Capabilities from Acorda Therapeutics GN jerrykrause 0 1/15/2021 12:39:08 AM
79 Kyle Bass's Petitions Challenging 2 Acordia Patents Rejected GN Tesk 0 8/24/2015 9:57:28 PM
78 fampridine development challenge GN Tesk 0 2/11/2015 12:20:31 AM
76 Form 4 GN investandgamble 0 10/17/2013 7:53:40 AM
75 Acorda Therapeutics Presents Positive Dalfampridine-ER Data in Post-Stroke Deficits at American Neurological Association 2013 Annual Meeting GN investandgamble 1 10/14/2013 8:20:49 AM
74 Acorda Receives Five Awards, Including PM360 Trailblazer Award as Best Specialty Pharma/Biotechnology Company GN investandgamble 0 10/10/2013 7:15:11 AM
73 Acorda Therapeutics Announces Initiation of Second Phase 1 GGF2 Clinical Trial in Heart Failure GN investandgamble 0 10/8/2013 7:23:51 AM
72 Acorda Therapeutics Appoints Michael Rogers Chief Financial Officer; David Lawrence Named Chief of Business Operations GN investandgamble 0 10/7/2013 7:26:24 AM
71 Acorda to Present New Research on AMPYRA(R) (dalfampridine-ER) at 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) GN investandgamble 0 10/2/2013 7:45:46 AM
70 Acorda Therapeutics Announces Initiation of Phase 2 Trial of Treatment for Spinal Cord Injury GN investandgamble 1 9/25/2013 10:55:33 AM
Previous 68 Messages Top of Message List Post Message Go to Msg #  




Financial Market Data provided by
.
Loading...